$VCYT VERACYTE, INC. Insider Trading
Get free email notifications about insider trading in VERACYTE, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in VERACYTE, INC.. Insider overview, share value development, latest insider transactions and email notifications about new events in VERACYTE, INC. for free.
IRS Number: 205455398
Industry: SERVICES-MEDICAL LABORATORIES [8071]
Trading Symbol: VCYT
Company Address: 6000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO 94080
Phone number: 650-243-6300
Former name: CALDEROME INC, date of change: 2006-12-19
Veracyte, Inc. engages in the research, development and commercialization of diagnostic products. The firm's portfolio includes Afirma, Percepta, and Envisia. It intends to treat thyroid cancer, improve lung cancer screening, and clarify the diagnosis of idiopathic pulmonary fibrosis. The company was founded by Bonnie H. Anderson and Y. Douglas Dolginow on August 15, 2006 and is headquartered in South San Francisco, CA.
Market Capitalization: $210.46M
Prev close: $7.58
Average Daily Volume: 130,463
Days Low: $7.20
Year Low: $4.21
Year High: $8.45
VERACYTE, INC. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 04 2021 | VCYT | VERACYTE, INC. | Holstein Jens | Director | Buy | P | 35.19 | 2,000 | 70,389 | 2,000 | 0 to 2 K |
| May 05 2021 | VCYT | VERACYTE, INC. | EASTHAM KARIN | Director | Sell | S | 50.03 | 250 | 12,507 | 8,800 | 9.1 K to 8.8 K (-2.76 %) |
| May 05 2021 | VCYT | VERACYTE, INC. | EASTHAM KARIN | Director | Sell | S | 49.00 | 650 | 31,849 | 9,050 | 9.7 K to 9.1 K (-6.70 %) |
| May 05 2021 | VCYT | VERACYTE, INC. | EASTHAM KARIN | Director | Sell | S | 48.01 | 3,527 | 169,344 | 9,700 | 13.2 K to 9.7 K (-26.67 %) |
| Apr 05 2021 | VCYT | VERACYTE, INC. | Alley Beverly Jane | VP, Corporate Contr ... | Option Exercise | A | 52.72 | 6,000 | 316,320 | 6,000 | |
| Mar 23 2021 | VCYT | VERACYTE, INC. | Bhanji Muna | Director | Grant | A | 0.00 | 11,541 | 0 | 11,541 | 0 to 11.5 K |
| Mar 23 2021 | VCYT | VERACYTE, INC. | Bhanji Muna | Director | Grant | A | 0.00 | 11,541 | 0 | 11,541 | 0 to 11.5 K |
| Mar 08 2021 | VCYT | VERACYTE, INC. | Kennedy Giulia C | Chief Scientific & ... | Option Exercise | M | 24.69 | 17,500 | 432,075 | 52,500 | |
| Mar 08 2021 | VCYT | VERACYTE, INC. | Kennedy Giulia C | Chief Scientific & ... | Option Exercise | M | 20.21 | 3,750 | 75,788 | 30,000 | |
| Mar 08 2021 | VCYT | VERACYTE, INC. | Kennedy Giulia C | Chief Scientific & ... | Option Exercise | M | 5.98 | 4,407 | 26,354 | 17,625 | |
| Mar 08 2021 | VCYT | VERACYTE, INC. | Kennedy Giulia C | Chief Scientific & ... | Option Exercise | M | 9.05 | 5,313 | 48,083 | 0 | |
| Mar 08 2021 | VCYT | VERACYTE, INC. | Kennedy Giulia C | Chief Scientific & ... | Sell | S | 55.49 | 300 | 16,647 | 53,724 | 54 K to 53.7 K (-0.56 %) |
| Mar 08 2021 | VCYT | VERACYTE, INC. | Kennedy Giulia C | Chief Scientific & ... | Sell | S | 54.72 | 1,431 | 78,310 | 54,024 | 55.5 K to 54 K (-2.58 %) |
| Mar 08 2021 | VCYT | VERACYTE, INC. | Kennedy Giulia C | Chief Scientific & ... | Sell | S | 53.50 | 2,606 | 139,414 | 55,455 | 58.1 K to 55.5 K (-4.49 %) |
| Mar 08 2021 | VCYT | VERACYTE, INC. | Kennedy Giulia C | Chief Scientific & ... | Sell | S | 52.38 | 5,032 | 263,564 | 58,061 | 63.1 K to 58.1 K (-7.98 %) |